Diapulse Corporation of America announces that the Centers for Medicare and Medicaid Services (CMS) will begin Medicare coverage implementation for the Diapulse Wound Treatment System.
       The Healthcare Common Procedure Coding System (HCPCS) established an applicable new code that will cover Diapulse treatment. Under Nationally Covered Indications, the use of Diapulse therapy will be covered for payment as an adjunct for chronic stage 3 or stage 4 pressure ulcers, arterial ulcers, diabetic ulcers, and venous stasis ulcers.
       With Medicare coverage, the addition of Diapulse medical technology will allow institutions, such as hospitals and nursing homes, to provide improved quality of patient care as well as a platform for cost savings.
       A significant advantage of Diapulse, nonthermal pulsed electromagnetic energy, is that it can treat wounds safely and effectively directly through bandages, clothing, and surgical dressings.
For more information about Diapulse Corporation of America, visit www.diapulse.com.